Imfind this one interesting. Lung Cancer. It seems they are checking parients post surgery or treatment check for rroccurence. My take is they check up to 3 years years after treatment. I think they see whether they diagnose before other methods. Interested in other opinions.
https://clinicaltrials.gov/ct2/show/NCT01840150
You can see by their history that the study was supposed to complete in Oct 2020, was pushed out to Oct 2021 and now is aniticipated to finish in Nov 2022. With them checking post treatment for 3 years this aligns with Brainchip and then Akida SOC IMO.
http://clinicaltrials.gov/ct2/history/NCT01840150?A=12&B=13&C=Side-by-Side#StudyPageTop
SC
Imfind this one interesting. Lung Cancer. It seems they are...
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.005(2.00%) |
Mkt cap ! $454.7M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.0¢ | 24.0¢ | $2.351M | 9.583M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 212207 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 372207 | 12 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
24.5¢ |
Change
-0.005 ( 2.00 %) |
||||
| Open | High | Low | Volume | ||
| 24.5¢ | 25.0¢ | 24.0¢ | 7464422 | ||
| Last updated 15.58pm 03/05/2024 ? | |||||
| BRN (ASX) Chart |